|Bid||7.05 x 3000|
|Ask||7.25 x 1200|
|Day's Range||6.09 - 7.46|
|52 Week Range||0.96 - 13.65|
|Beta (5Y Monthly)||1.74|
|PE Ratio (TTM)||40.77|
|Earnings Date||Aug 17, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Retractable Technologies' (NYSEMKT:RVP) stock is up by a considerable 37% over the past three months. We wonder if and...
Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $960 thousand in the second quarter of 2020, compared to an operating income for the same period last year of $329 thousand, and that income applicable to common shareholders was $3.6 million for the second quarter of 2020. During the second quarter, Retractable had an increase in net sales of approximately $2.0 million over the prior period, of which $1.4 million is attributable to sales to the U.S. Department of Health and Human Services under a previously reported $83.8 million delivery order. Other material changes in the Statement of Operations for the three months ended June 30, 2020 include an unrealized gain of approximately $900 thousand in an investment account and a recognition of approximately $1.8 million in deferred tax assets. Retractable also reports recent activity under the $53.7 million Technology Investment Agreement with the U.S. government, including placing orders for approximately $20 million in equipment and engagement of professionals to expand Retractable’s facilities in Little Elm, Texas.
The company's been awarded a multimillion-dollar government COVID-19 contract to expand production of needles and syringes.